Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: BRCA1 Mutation|Breast Cancer|Breast Diseases|Breast Neoplasms|Breast Carcinoma|Neoplasms
Interventions: DRUG: Denosumab|DRUG: Placebo|OTHER: Quality-of-Life Assessment
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)|Austrian Breast & Colorectal Cancer Study Group (ABCSG)